pendulum wbf-038
Cell therapyexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started May 31, 2022 (NCT05348694)
Timeline
Indications
Mechanism of action
- microbiotaTissue restoration
microbiota tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07044310 | Phase 2 | Jul 25, 2025 | Mayo Clinic |
| NCT05348694 | Phase 1/Phase 2 (Phase 2) | May 31, 2022 | Australian Catholic University, Curtin University, Pendulum Therapeutics |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Australian Catholic University | Academic/Hospital | 1 | 1 | 1 | 2022 |
| Curtin University | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Mayo Clinic | Academic/Hospital | 1 | 1 | 1 | 2025 |
| Pendulum Therapeutics | For profit | 1 | 0 | 1 | 2022 |
4 organizations
Page 1 / 1